These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3515119)

  • 1. Potentiation of glucose-stimulated insulin release by tolazamide and paradoxical absence of glucose facilitation (Staub effect) in non-insulin-dependent diabetes.
    Reich A; Abraira C; Brunken R; Soneru I
    Metabolism; 1986 Apr; 35(4):367-70. PubMed ID: 3515119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of glucose-primed intravenous glucose tolerance and correction of acute insulin decrement by glipizide in type II diabetes.
    Ravanam A; Jeffery J; Nehlawi M; Abraira C
    Metabolism; 1991 Nov; 40(11):1173-7. PubMed ID: 1943745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of Staub Effect and amelioration of insulin secretion defects after glyburide treatment in non-insulin-dependent diabetes.
    Soneru IL; Hein N; Jeffery JD; Abraira C
    Diabetes Res; 1990 Oct; 15(2):77-83. PubMed ID: 2132401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of glucose tolerance and insulin secretory response to repeated glucose levels by the feeding of minimal glucose during prolonged fasting.
    Abraira C; Lawrence AM
    Metabolism; 1981 Dec; 30(12):1200-8. PubMed ID: 7031419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.
    Maloff BL; Lockwood DH
    J Clin Invest; 1981 Jul; 68(1):85-90. PubMed ID: 7019248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM.
    Karam JH; Sanz N; Salamon E; Nolte MS
    Diabetes; 1986 Dec; 35(12):1314-20. PubMed ID: 3533680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial.
    Firth R; Bell P; Marsh M; Rizza RA
    Diabetes; 1987 Oct; 36(10):1130-8. PubMed ID: 3308584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of the Staub-Traugott effect in endotoxicosis.
    Inaba H; Filkins JP
    Circ Shock; 1991 Aug; 34(4):398-404. PubMed ID: 1773482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats.
    Salhanick AI; Konowitz P; Amatruda JM
    Diabetes; 1983 Mar; 32(3):206-12. PubMed ID: 6337899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and C-peptide secretion in non-insulin-dependent diabetes mellitus and its response to dietary therapy.
    Beatty OL; Bell PM; Hadden DR; Atkinson AB; Kennedy L
    QJM; 1995 Apr; 88(4):257-62. PubMed ID: 7796075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat.
    Doshi LS; Brahma MK; Sayyed SG; Dixit AV; Chandak PG; Pamidiboina V; Motiwala HF; Sharma SD; Nemmani KV
    Metabolism; 2009 Mar; 58(3):333-43. PubMed ID: 19217448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of facilitated glucose disposal (Staub-Traugott effect) in subjects with hypopituitarism.
    Abraira C; Graham LA; Lawrence AM
    Metabolism; 1975 Oct; 24(10):1145-55. PubMed ID: 1165729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes.
    Turtle JR
    Br Med J; 1970 Sep; 3(5723):606-10. PubMed ID: 5470087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
    Féry F; Balasse EO
    Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral tissue glucose uptake is not reduced after an oral glucose load in Southern Italian subjects at risk of developing non-insulin-dependent diabetes mellitus.
    Thorburn AW; Proietto J
    Metabolism; 1999 Jan; 48(1):80-5. PubMed ID: 9920149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus.
    Kahn SE; Montgomery B; Howell W; Ligueros-Saylan M; Hsu CH; Devineni D; McLeod JF; Horowitz A; Foley JE
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5824-9. PubMed ID: 11739446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate.
    Kanatsuka A; Makino H; Sakurada M; Hashimoto N; Iwaoka H; Yamaguchi T; Taira M; Yoshida S; Yoshida A
    Metabolism; 1988 Sep; 37(9):878-84. PubMed ID: 3047522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nifedipine on glucose potentiation of the acute insulin response to arginine in non-insulin-dependent diabetics.
    Krempf M; Ranganatan S; Ritz P; Garnier JM; Charbonnel B
    Eur J Clin Pharmacol; 1991; 41(5):411-5. PubMed ID: 1761067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.